RecruitingNot ApplicableNCT02604277

Suicidal Behavior in Patients Diagnosed With Bipolar Disorder

Suicidal Behavior in Patients Diagnosed With Bipolar Disorder: The Roles of Biological and Childhood and Adult Environmental Risk Factors


Sponsor

Emory University

Enrollment

130 participants

Start Date

Jan 1, 2016

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to learn the environmental and psychological factors that impact suicidality in patients diagnosed with Bipolar Disorder. Additionally, the study aims to identify treatments to reduce the suicidal behavior and improve quality of life through a 6-week group-based intervention program.


Eligibility

Min Age: 18 YearsMax Age: 64 Years

Plain Language Summary

Simplified for easier understanding

This study is examining suicidal behavior in people diagnosed with bipolar disorder — collecting information about their experiences, moods, and history — to better understand what drives suicidal thoughts and actions in people with this condition. **You may be eligible if...** - You have been diagnosed with bipolar disorder - You speak English - You are able to provide written informed consent **You may NOT be eligible if...** - You have significant cognitive impairment (memory or thinking problems) - You are currently experiencing psychosis (losing touch with reality) - You are medically unstable - You have a history of schizophrenia or related psychotic disorders - You have a history of substance use disorder as your primary diagnosis - You have a primary organic brain disease or dementia Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALInterpersonal and Social Rhythm Therapy (ISRT)

Interpersonal and Social Rhythm Therapy (ISRT) will be given once a week over a six week period for 55-60 minutes. ISRT emphasizes identifying and maintaining a regular routine in daily life. It includes addressing sleep and solving interpersonal concerns and conflicts by focusing on daily routine.

BEHAVIORALBipolar-Specific Cognitive Behavioral Therapy (CBT)

Bipolar-Specific Cognitive Behavioral Therapy (CBT) will be given once a week over a six week period for 55-60 minutes.The therapy is directly focused on eliminating or managing specific problems experienced by people with Bipolar Disorder. As part of this intervention, participant's maladaptive thoughts, behaviors and emotions are identified followed by learning how to challenge negative thoughts and reframing into positive, more adaptive thoughts. Additionally, the intervention involves enhancing the participant's coping skills and the ability to view a situation more objectively.

BEHAVIORALMindfulness-Based Stress Reduction (MBSR)

Mindfulness-Based Stress Reduction (MBSR) will be given once a week over a six week period for 55-60 minutes. MBSR is a structured intervention that utilizes mindfulness meditation to reduce suffering associated with physical and psychiatric illnesses. MBSR is nonreligious in nature and aims to encourage an enhanced awareness of moment-to-moment experience of noticeable mental processes.

BEHAVIORALPsycho-education & Understanding Bipolar Medications Therapy

Psycho-education \& Understanding Bipolar Medications Therapy will be given once a week over a six week period for 55-60 minutes. Psycho-education \& Understanding Bipolar Medications Therapy aims to provide psycho-education about Bipolar Depression as well as provide a platform for participants to address concerns about managing their illness. Issues such as managing symptoms, reducing relapses and hospitalizations as well as maintaining gains will be discussed


Locations(1)

Grady Health System

Atlanta, Georgia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02604277


Related Trials